Article Information
History
- January 27, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- C. Vermeulen1,2,†,
- M. Pagès-Gallego1,2,†,
- L. Kester3,
- M.E.G. Kranendonk3,
- P. Wesseling3,4,
- J. van der Lugt3,
- K. van Baarsen3,
- E.W. Hoving3,
- B.B.J. Tops3 and
- J. de Ridder1,2,*
- 1Oncode Institute, The Netherlands
- 2Center for Molecular Medicine, UMC Utrecht, Heidelberglaan 100, Utrecht, The Netherlands
- 3Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- 4Department of Pathology, Amsterdam University Medical Centers/VUmc, Amsterdam, The Netherlands
- ↵*Corresponding author(s). E-mail(s): j.deridder-4{at}umcutrecht.nl
↵† These authors contributed equally to this work.
Posted January 27, 2023.
